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Abstract 
Background: 
 In Howard, Best and Nickels (2015, this issue) we presented a set of ideas relevant to the design of 
single case studies for evaluation of the effects of intervention. These were based on experience 
with intervention research, methodological expertise and a set of simulations. Our discussion and 
conclusions were not intended as guidelines (of which there are several in the field) but rather had 
the aim of stimulating debate and optimising designs in the future.  Our paper achieved the first aim 
- it received a set of varied commentaries, not all of which felt we were optimising designs, and 
which raised further points for debate. 
Aims:  
In this paper, respond to the commentaries, and examine the guidelines for evaluation of the design 
of single case studies proposed by Tate, Perdices, Rosenkoetter, Wakim, Godbee, Togher & 
McDonald (2013). We aim to further the discussion our target article has started and extend the 
scope more broadly to issues that were not discussed in our target article (e.g. replication)  
Main Contributions & Conclusions: 
 It is clear that there is a strong consensus that adequately designed single case studies of 
intervention are an appropriate and important tool in our quest for effective interventions with 
people with cognitive disorders. It is also the case that many agree that there is no single design that 
is appropriate for every intervention, every participant or every question. However, whichever 
design is used it must be able to discriminate between the true effect of an intervention on 
behaviour, and other potential reasons for change (e.g. practice effects, spontaneous recovery, 
Hawthorne effects, placebo effects). We have suggested that, depending on the conditions and 
question to be addressed, this can be achieved using a combination of design features. These may 
include: multiple pre-treatment baselines, treated and untreated (or subsequently treated) 
items/processes/tasks, control tasks (not predicted to be affected by treatment even when 
generalisation is expected), and a cross-over phase (replication across items/tasks). In addition, the 
outcome of treatment should be evaluated statistically.  
We note that generalisation which is clinically desirable, can lead to particular difficulties in 
attributing change to intervention unless appropriate controls have been included, and that when 
items are selected on the basis of poor pre-treatment performance, apparent treatment-related 
gains may in fact be due to regression to the mean and discuss the implications of this for future 
research. 
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In Howard, Best and Nickels (2015, this issue), we discussed of some of the features of different 
designs for evaluating the outcome of intervention at the level of the individual. These included 
aspects of the different phases of a study (pretherapy, therapy phase and post therapy), assignment 
of items to conditions (and the problem of regression to the mean) and different methods of 
analysis, including presentation of a statistical method based on λ coefficients that we called 
‘Weighted  Statistics’ (WEST).  
As Hillis (2015, this issue) notes we did not, nor did we intend to, provide comprehensive guidelines 
nor definitive criteria regarding single case experimental design for intervention. Rather we hoped to 
stimulate discussion and provide pointers for the future. We are pleased that so many of those 
prominent in the field chose to provide commentaries and develop the discussion beyond our 
starting point.  In this response to the commentaries, we will take the opportunity to clarify our 
approach and discuss some ways in which it may be sensibly extended. We also will make explicit 
some aspects of our philosophy that were not the focus of our original article. 
We structure this response around a welcome move in the field - the first attempt to develop clear 
guidelines for rating the methodological quality of single case experimental designs for intervention: 
The Risk Of Bias in N-Of-1 Trials (ROBiNT) rating scale (Tate, Perdices, Rosenkoetter, Wakim, Godbee, 
Togher & McDonald, 2013). Using this scale as a starting point, we reflect on the different views on 
experimental design for intervention, their similarities and differences. A key issue is the extent to 
which different designs maintain 'experimental control' and we discuss the requirements for 
experimental control and the different ways this may be achieved. ‘Experimental control’ means, at 
least as a first approximation, that it is clear that the change of performance by a participant can 
only be as a result of an intervention, and not due to other factors such as spontaneous recovery or 
change, measurement error or poor experimental design. 
The ROBiNT rating scale (Tate et al., 2013) built on the earlier Single-Case Experimental Design Scale 
(Tate, McDonald, Perdices, Togher, Schulz and Savage, 2008). The 2008 scale was focused upon 
weaknesses of single-subject designs in terms of their threats to validity. They cite 6 key problems 
with single case designs and map these on to possible solutions and criteria used in the scale (Tate et 
al., 2008, Table 1): Understanding of the problem issue, determining treatment efficacy, variability in 
behaviour, observer bias, verification of treatment efficacy and generalisation. The ROBiNT scale 
amended and refined the Tate et al. scale adding five new items. 
Table 1 summarises the items in this scale and, many, we are confident, are uncontroversial. For 
example, few would disagree that using independent assessors blind to the phase of intervention 
will reduce the risk of even unintentional bias in the interpretation of results (ROBiNT 5: Blinding 
assessors). Similarly, measures of inter-rater reliability in coding of observations will ensure that the 
results are reliable (ROBiNT 6: Inter-rater reliability). Like McDonald (2015, this issue), we also fully 
support the need for the raw data to be provided (ROBiNT 12: Raw data record)1. If, for example, the 
presentation is limited to means of results from each phase, this can obscure the variability and 
                                                          
1
 Figure 1 in Howard et al. only provides the mean of three pre-therapy baselines and two post-therapy 
baselines. This was done in order to focus attention on the problem of regression to the mean. If a figure like 
this were to be presented in a report of a single case treatment study, it would be essential that raw data for 
every testing point was also provided (most probably in a table).  
5 
 
overall trend in the data. Moreover, we would go further in suggesting that item-level scores should 
always be made available, at least for the primary outcome measure. This can often now be done by 
providing supplementary data to a paper, and allows for the possibility of meta-analysis (Beeson, 
2015, this issue). 
 
TABLE 1 : Subscales of the Risk Of Bias in N-Of-1 Trials (ROBiNT) rating scale (Tate et al.,  2013). 
 Items 2, 4, 7, 9 and 11 were additions to the ROBiNT scale, and did not appear in the earlier Single-
Case Experimental Design Scale (Tate et al, 2008). 
Internal validity subscale 
1. Design  
2. Randomisation  
3. Sampling behaviour (all phases)  
4. Blinding patient/therapist  
5. Blinding assessors  
6. Inter-rater reliability  
7. Treatment adherence 
External validity and interpretation subscale 
8. Baseline characteristics  
9. Therapeutic setting  
10. Dependent variable (target behaviour)  
11. Independent variable (intervention)  
12. Raw data record  
13. Data analysis  
14. Replication  
15. Generalisation 
 
Blinding of the participant and therapist (ROBiNT point 4: Blinding patient/therapist) is a complex 
issue. It may be feasible and appropriate to blind to the nature of the intervention for some 
interventions such as computer delivered programmes but it is rarely possible to blind to the phase 
of the study (intervention or assessment). Indeed, it may not be appropriate in many cases. For 
example, in many clinical interventions, participants will be involved in selecting their own 
rehabilitation targets and the process of working towards these is likely to be explicit specifically to 
increase motivation. This may be true for a range of interventions where a focus on impairment 
(such as in writing) may be to reach a functional goal (e.g. composing e-mails to a relative). Similarly, 
there are also a set of approaches where the metacognitive or metalinguistic aspect is core to the 
therapy, including for example, self-cueing (e.g., Nickels, 1992), use of a cueing-aid (e.g., Best, 2005; 
Bruce & Howard, 1987) or conversational approaches (e.g., Beeke, Beckley, Johnson, Heilemann,  
Edwards, et al, in press). In these approaches, blinding would never be possible, and a study without 
such blinding should not be penalised. 
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We also agree that there is a need to demonstrate that the positive results of treatment can be 
replicated across different individuals and therapists (ROBiNT 14: Replication). But, this replication 
does not affect the strength of the conclusion that can be drawn regarding the presence of 
treatment effects for a particular individual. We return to the issue of replication in the discussion of 
design below. Finally, it is clearly valuable for an intervention study to enable evaluation of the 
extent of any generalisation (ROBinT: 15 Generalisation) from the target task (e.g word retrieval in 
picture naming) to other, perhaps more functional tasks (e.g. word retrieval in conversation). Or, 
alternatively, to investigate generalisation from the targeted setting (e.g. conversation with a 
spouse) to another setting (e.g. conversation with a different familiar or unfamiliar partner). 
It is issues to do with design (ROBiNT 1: Design, ROBiNT 3: Sampling behaviour, ROBinT 14: 
Replication) and analysis (ROBiNT 13 Analysis) where there is the most debate and controversy and 
this is reflected in the commentaries on our target article (Howard et al., 2014, this issue). Before we 
discuss these issues we will first briefly reflect on some of the other points in the scale. 
 
Specification of Intervention and its target behaviour 
It is uncontroversial that both the intervention (ROBiNT 11: Independent variable) and the target 
behaviour (ROBiNT 10: Dependent variable; e.g. accuracy of reading aloud of nonwords; accuracy of 
picture naming; grammatical complexity in conversation) need to be precisely described.  
The intervention should always be described in the detail needed to allow replication of the 
technique. Nevertheless, it is surprising how often, when one comes to attempt precise replication 
of a treatment, it becomes clear that the detail necessary is simply not provided. For example, all of 
us have been involved in (independent) studies where the treatment was to be based on Semantic 
Feature Analysis. Our literature searches found many studies using Semantic Feature Analysis but 
none of them specified the treatment in the detail we needed to develop clear treatment protocols 
(and it was clear that ‘Semantic Feature Analysis’ was in fact many different treatments because the 
way in which it was implemented varied (Boyle, 2011)).  
Coltheart (1983) writes that the treatment should be “described in sufficient detail to allow it to be 
exactly duplicated by other therapists working with other patients” (pp. 198-9). As Howard (1986) 
points out, “The only trials that can be used to modify and improve clinical therapy are those where 
the treatment involved is specified in at least ‘cook book’ detail” (p. 95).  Over the last couple of 
years there have been some initiatives from those involved in Randomised Controlled Trials to set 
minimum standards for the description of behavioural interventions (Boutron, Moher, Altman, 
Schulz & Ravaud, 2008; Hoffmann et al., 2014) . However, these are just minimum standards and 
they don’t always require full detail on behavioural interventions. Included in the description of 
intervention should be specification of what was done, and exactly how it was done. For example, 
the number of sessions, the timing and duration of those sessions, and the number of ‘treatments’ 
per item per session (dose) should all be clear. However, there also needs to be specification of what 
may seem like minutiae. For example, if the task was judging whether a picture and a word matched 
– was the picture provided first and the participant given time to think about the name, before the 
word is provided? Or were picture and word provided simultaneously. It is possible that the two 
different presentations of the same task may lead to different processing demands (attempted 
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naming in the former but perhaps not in the latter). These different processing demands may lead to 
different outcomes of intervention. 
Similarly, all the different response possibilities should be clearly specified. For example what 
happened when the person failed to respond, responded incorrectly, asked for repetition? What 
feedback (if any) was given regarding their response? These factors may or may not influence the 
outcome. We have no idea without empirical data how important these factors might be. For 
example, Nickels and Best (1996), showed that for one man, AER, the same treatment technique 
produced different outcomes depending on whether or not there was feedback on and discussion of 
the responses made. 
With the move towards treatment manuals and publication of study protocols we hope that the 
ability to truly replicate a treatment exactly will improve. However, even when the treatment it is 
fully specified it also important to document to what extent the protocol was followed (ROBiNT 7: 
Treatment adherence). This includes adherence by the treating clinician: For example, if the protocol 
says ‘no feedback’, how often did the clinician, under pressure from their therapeutic training or the 
client, relent and provide feedback? Or if the picture and word were to be provided simultaneously 
for judgement, how often was the picture provided first? Delivery of treatment using computer 
programmes and apps will increase the standardisation and reproducibility of treatment delivery, 
but still does not guarantee full adherence to the planned protocol. Treatment adherence also 
includes adherence by the participant and those around them. For example, when asked to judge 
whether a picture and written word match, but not to read the written word aloud, does the 
participant comply or do they read the word aloud on some sessions or trials? Or might, as we 
experienced in a home programme, a well-meaning friend write down the names of the items in the 
treatment set as an additional cue, and change the target word for some stimuli (Mason, Nickels, 
McDonald, Moses, Makin and Taylor, 2011)! 
The setting of the therapy may influence outcomes and should also be specified (ROBiNT 9: 
Therapeutic setting). This may seem less important for some interventions (such as a word retrieval 
treatment involving repetition of a word in the presence of a picture) but for others the potential 
impact is obvious (such as practising the use of scripts for ordering a drink in the clinic versus in a 
cafe setting). 
Specification of the characteristics of the individual 
It is important that the characteristics of the individual participating in the intervention are fully 
described (ROBinT 8: Baseline characteristics; Roberts, Code & McNeil, 2003). If the intervention is 
effective, future attempts at replication will need to use these characteristics as a reference point. 
Unfortunately, however, it is not easy to specify which characteristics are important. It is clear that 
the particular impairment under consideration should be defined and defined in some detail. For 
example, if the treatment is for a spoken word retrieval (naming) impairment then it is not sufficient 
to say that the participant had impaired picture naming, but to also specify the level of impairment 
(e.g. semantic impairment, access to phonological output lexicon). For example, Nickels (1992) 
aimed to carry out a replication of treatment to improve sublexical reading skills (measured by 
nonword reading) that had previously been successfully used by De Partz (1986). Both TC (Nickels, 
1992) and SP (De Partz, 1986) had impaired nonword reading and an inability to convert graphemes 
to phonemes. However, following treatment to reteach grapheme phoneme correspondences, SP’s 
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nonword reading improved but TCs did not. It became apparent that TC also had an impairment to 
another component of the sublexical reading system (the ability to blend phonemes), which we have 
to assume was intact in SP. This was why, despite relearning grapheme-phoneme correspondences, 
he remained unable to read nonwords aloud. This case illustrates how the absence of a 
comprehensive analysis of the processing components of the target behaviour can severely limit the 
ability to replicate intervention studies. 
However, even a detailed analysis of the impairment underlying the target behaviour may be 
insufficient to ensure replicability of results. Nickels and Best (1996), for example, performed the 
same intervention (word-picture matching) with three individuals who seemed to have the same 
level of impairment in the target behaviour (naming). However, all three responded differently to 
the treatment. Consequently, it is important that background testing is more comprehensive: Other 
aspects of language processing need to be assessed, in particular those that may be involved in the 
therapy task. Best and Nickels (2000) recommend a ‘microanalysis’ of deficits, strengths and therapy 
tasks. For example, in a treatment that involves word repetition, the extent to which repetition is 
impaired or intact is relevant, and perhaps the extent to which the word that is provided for 
repetition can also be comprehended. Similarly, it has been hypothesised that non-linguistic 
cognitive processing influences the success of treatment (e.g., Fillingham, Sage & Lambon Ralph, 
2005). In which case it is also essential to test cognitive processing that may influence treatment 
outcomes and also that may be required for a particular treatment task to be carried out 
successfully (e.g. working memory in a word-picture matching task).  
Indeed, Rapp, Caplan, Edwards, Visch-Brink and Thompson (2013) suggest that broad and 
comprehensive measurement is required not only prior to treatment but also there is a need to 
measure widely after treatment. Their argument is that if one is going to draw conclusions about the 
impact of a therapy on the language system, then a comprehensive analysis is also required after 
treatment to identify how it has changed. For studies which aim to relate changes in neural activity 
to effects of treatment, it is particularly important to demonstrate that there is change only in those 
processes claimed to have changed as a result of treatment. 
 We turn now to the three key areas over which there is continuing controversy. 
 
Design  
It is in the area of the design of single case studies of intervention that there is the strongest debate 
and this is reflected in the commentaries. We first reiterate our concern that by restricting the use of 
the term ‘single case experimental design’ (of intervention) to a particular class of designs some 
authors are being overly restrictive, and indeed, Goldstein (2015, this issue) particularly objects to 
our more liberal use of this term. Nevertheless, rather than there being a single defensible approach, 
there are a variety different kinds of single case experimental designs for intervention each with 
strengths and weaknesses (see also, e.g., Beeson, 2015, this issue; Hillis, 2015, this issue; Johnson & 
Kiran, 2015, this issue; Laganaro, 2015, this issue). As Beeson (2015, this issue) suggests, exactly 
which design is chosen will be affected by experiment-specific factors, including the phase of 
research, participant characteristics, and the anticipated response to treatment. 
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All designs examine single cases and use a variety of methods in an effort to maximise experimental 
control. Of these different approaches, those we labelled Approach A and B are a subset. Approach 
A is that advocated by, for example, Thompson (2006; 2015, this issue) and Goldstein (2015, this 
issue). Approach B is that advocated by our target article (Howard et al., 2015, this issue) and many 
from within the cognitive neuropsychological approach (e.g., Byng & Coltheart, 1986; Franklin, 1997; 
Nickels, 2002b). 
Goldstein (2015, this issue) is concerned that we were confusing single case experimental designs 
with case studies. We were (and are) not. We agree with Goldstein that this would be misguided: In 
this use of the term, ‘case studies’ refers to descriptive studies that do not have any experimental 
control to allow determination of whether intervention is the source of any change in behaviour (see 
also Tate et al, 2013).  Tate et al. (2013), in their Figure 1, clearly set out those designs which they 
believe have experimental control and hence can be called single case study experimental designs 
and those that do not. Designs which are excluded include biphase (A-B) designs (where, as is 
standard, A refers to a baseline phase and B to a treatment phase) and ‘pre-post’ designs. We have 
concerns with these exclusions, in the text, Tate et al further specify that by ‘pre-post’ they mean 
"pre-test/post-test type of studies of an individual (where data are not collected during the 
treatment phase)" (p623). We argue that both biphase and pre-post designs can indeed have 
experimental control and moreover that experimental control is not all or none. What differs across 
(and within) designs is the confidence with which one can attribute the results to treatment-specific 
effects: the more restricted the effects of treatment (e.g., item specific effects) the fewer 
methodological controls are required to be able to unambiguously attribute these effects to 
treatment (i.e. to maintain experimental control). 
Given the debate regarding the issue of experimental control, it is worthwhile to take some time 
clarifying our position (see also, Byng & Coltheart 1986; Franklin, 1997; Nickels, 2002b). To be 
specific, if an intervention study has experimental control it means that it has the ability to attribute 
any change to the specific effects of intervention and to exclude the possibility that they could 
instead be due to factors other than the intervention. 
Pre-test – post-test design 
The most simple pre-post design is one where there is a single pre-test and a single post-test with a 
treatment period intervening (see Figure 1)2. Figure 1a illustrates the case where assessment is of 
items that have been treated (such as the names of a set of pictures) or items sampling processes 
that have been treated (such as nonwords for reading that include treated letter-sound 
correspondences). It is clear there has been a change between Pre and Post assessment points, 
however, it is not possible to attribute this to treatment – there is no experimental control. The 
improvement could be due to spontaneous recovery, practice effects, placebo effects, Hawthorne 
                                                          
2
 We believe that pre-post designs represent a minimal ABA design: performance is assessed once during a no 
treatment phase (A), then treatment is applied (B) but performance is not probed, followed by assessment 
once at the beginning of the second no treatment phase (A). There could be an argument, however, that they 
represent an AB design: the post-test could be the last (and only) point in the treatment phase (see e.g., 
Laganaro, 2015, this volume). However, the terminology itself is not of importance, what is vital is that there is 
an understanding of the strengths and weaknesses of a particular design. 
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(charm) effects, or any other 'extraneous’ variable. Greater experimental control can be gained in a 
number of ways. In Figure 1b, there is additional sampling of another set of items which are not 
treated (labelled ‘untreated’). These items show no improvement. This provides some experimental 
control – if the improvement on the treated set had been the result of spontaneous recovery, 
practice, placebo or Hawthorne effects or any other factor, it would have applied equally to the 
treated and untreated items tested on the same task and randomly interleaved. The fact that the 
untreated items did not improve suggests that it was indeed the treatment that improved 
performance for the treated items3.  
While we would not advocate the use of such a simple design when embarking on intervention 
research, we would argue that it is NOT the case that this design has no experimental control, 
contrary to the claim of Tate et al. (2013).  
Thompson (2015, this issue) raises the concern that the untrained sets may not show improvement 
because they are in some way 'harder' than the treated sets. As we noted, to avoid this possibility, it 
is important that there is matching of (randomly allocated) items within sets for both accuracy and 
relevant psycholinguistic factors (e.g. frequency, imageability, number of phonemes, semantic 
category) and then the sets are randomly allocated to treatment or no treatment conditions. 
Kratchowill & Levin (2010, page 127) note that randomisation is an important feature that can 
enhance the scientific credibility of even the most basic design. Hence, if sets are not only matched, 
but also randomly allocated to treated and untreated conditions, it is extremely unlikely that one set 
will be ‘harder’. The use of statistics with randomly allocated sets necessarily takes into account the 
possibility of some (unanticipated) imbalance making one set harder. Nevertheless, it can, of course, 
be empirically demonstrated by including a second phase where the previously untreated items are 
treated (a cross-over phase; Figure 1c). If the untreated items show improvement, when treated, 
then this provides stronger evidence that the treatment has been effective, through a replication of 
the treatment effect (see also Laganaro, 2015, this issue).  
Generalisation across sets 
There are conditions under which this simple pre-post design loses experimental control: when both 
the treated and the untreated items (or items sampling treated and untreated processes) improve, 
as illustrated in Figure 1d. Here we are, once again, in the position that it is impossible to determine 
whether the change is due to treatment, which has generalised across items (perhaps by enabling a 
strategy, or by improving general underlying processes), or due to spontaneous recovery, 
Hawthorne effects etc. . 
 
 
                                                          
3
 For the sake of illustration we have not used statistical analysis here, however, we are committed to the view 
that these conclusions could only be drawn if 1) the treated items showed significant improvement and 2) the 
difference in any change was significantly greater for the treated than the untreated items. 
11 
 
 
 
Figure 1: Illustration of different possible patterns of improvement within an intervention design with a single pre-therapy probe and post-therapy 
probe.  Figure 1a illustrates a design with only treated item probes, Figure 1b illustrates improved experimental control by including an untreated set 
(which does not improve) and Figure 1c demonstrates that this untreated set improves when treatment is applied to it. Figure 1d illustrates improvement of 
both treated and untreated items in the treatment period. In Figure 1e addition to the design of a control task, which does not improve, suggests that the 
effects on treated and untreated items are a result of treatment. This conclusion is strengthened in the design in Figure 1f which demonstrates that the 
control task improves when treatment is directed to it.
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Generalisation across sets, while desirable for participants and clinicians, is a challenge for all 
experimental designs not just for this minimalist pre-post design. Thompson (2015, this issue, page 
XX) raises this issue, noting that "in Approach B, generalization across sets also renders the results as 
internally invalid". This can be true (but see below for design features commonly applied in 
Approach B to circumvent this problem). However, the same applies to Approach A – if, when the 
first phase of treatment is applied to the first set, there is change in the within treatment probes not 
only for the treated set but also for other sets, then there is a reduction in experimental control. In 
other words, if when treatment is applied, all the probed sets improve, Approach A also cannot 
distinguish between 'true' treatment effects and more general non-specific treatment effects 
(Hawthorne effects or placebo effects). 
Across both approaches generalisation, which is clinically desirable, can lead to difficulties in 
attributing change to intervention. Nevertheless, by incorporating additional design features, one 
can determine whether there really are treatment-specific effects. One possibility is to include the 
assessment of an additional task, process or set of items that is not predicted to improve as a result 
of treatment: a control task or item set. If this task/process/item set does not improve then it is 
more likely any change shown on the treated and untreated subsets of the treated task is due to 
treatment-specific effects. However,it is possible that the control task may simply be less susceptible 
to spontaneous recovery/practice or 'extraneous' effects. Hence a demonstration that this task 
improves when treatment is directed to it would provide greater strength of evidence (i.e., use of a 
cross-over design, see Figure 1f; e.g., Byng and Coltheart, 1986).  
In sum, we contest the view that pre-test post-test designs never have experimental control. Under 
certain conditions, they have sufficient experimental control to conclude that improvements to 
treated stimuli are a specific effect of the treatment - specifically, when stimuli are randomly 
assigned to conditions and there is no improvement to untreated stimuli,.  
However, we do not advocate the widespread use of pre-post designs with a single assessment at 
each point. Amongst other things, it is important to probe more than once after treatment in order 
to determine whether, and for how long, treatment effects maintain (Johnson & Kiran, 2015, this 
issue). Similarly designs where different treatment techniques are compared within an individual 
allow for refinement of hypotheses regarding treatment mechanisms (Laganaro, 2015, this issue). 
Finally, as we will demonstrate in the next section, probing more than once before treatment begins 
allows for a much more robust experimental design.  
 
Multiple baseline design 
If we return to the situation depicted in Figure 1a, where items improve when treatment is applied, 
another method by which further experimental control can be achieved is the use of more than one 
pretreatment probe – multiple baselines. The vast majority of single case intervention research 
incorporates more than a single pretreatment assessment reflecting the agreement across 
approaches regarding the importance of this design element (Beeson, 2015, this issue; Kearns, 2015, 
this issue).  
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Figure 2: Illustration of experimental control within a multiple baseline design with two 
pretreatment baselines. Figure 2a shows a situation where the trend is similar across baseline and 
treatment phases, whereas in Figure 2b, there is a clear distinction between the two phases with 
greater improvement over the treatment phase. Figure 2c shows the addition of an untreated 
condition, which does not improve, with 2d adding the additional control of this, previously 
untreated, set showing improvement when treatment is targeted to it. Figure 2e shows the situation 
where the untreated set also improves in the treatment phase, and 2f adds a control task to the 
design allowing dissociation of generalisation from other factors (e.g. Placebo effects), and 2g uses a 
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cross-over design to demonstrate that the control task can also improve when treatment is directed 
at it. 2h shows the condition where the control task also improves.   
 
These pre-treatment probes allow an estimate of the rate of change without intervention. This 
change could reflect spontaneous recovery and/or practice effects. If we compare the pattern across 
the two pretreatment probes (Pre1 and Pre2) in Figures 2a and 2b, suitable statistical analysis 
comparing the rate of change across the phases (e.g. WEST-ROC, Howard et al., 2015, this issue) 
would enable us to infer that in 2a, there is no effect of treatment, but rather the improvement in 
the treatment phase simply reflects a continuation of steady improvement over time. In contrast, in 
2b there seems to be an effect of treatment as there is a clear difference in the rate of change over 
the baseline (pre1-pre2) and treatment phases (pre2-post). However, we still cannot distinguish 
whether this difference is a 'true' effect of therapy or due to Hawthorne/placebo effects.  One 
option is to include regular contact with the therapist over the baseline phase (e.g. Best et al., 2011) 
that matches the intensity and duration of contact provided during the intervention. If there is 
greater change during the treatment phase within this design we can be sure it was not simply due 
to the Hawthorne effect. In this case a difference in improvement between the phases reflects an 
intervention effect surpassing any therapist charm. It is also possible that this contact with therapist 
could be perceived as ‘therapeutic’ and, particularly if participants are blinded, or otherwise 
unaware of the distinction between assessment and intervention sessions, then this manipulation 
may also  provide control for potential placebo effects. 
 Alternatively, as before, we can start to distinguish between effects of treatment and other factors 
by incorporating assessment of another, untreated, set of stimuli. Figures 2c and 2e again contrast 
the outcomes. In Figure 2c the untreated set shows no improvement, and as in Figure 1b, this 
provides evidence for specificity of treatment effect (and exclusion of Hawthorne and placebo 
effects). The inclusion of the two pretreatment baselines in Figure 2c simply increases the evidence 
compared to Figure 1b. Similarly, by including a replication of the effects by treating the previously 
untreated set (cross-over phase; see Figure 2d), the weight of evidence (or strength of experimental 
control) is further increased (as also suggested by Laganaro, 2015, this issue). In the scenario of 
Figure 2e, where both treated and untreated sets improve when treatment is given, we once again 
require a further methodological manipulation – addition of a control task to distinguish between 
Hawthorne/placebo effects and 'true' effects of treatment (see Figure 2f). The weight of evidence 
can be increased by demonstrating that this control task also improves when treatment is directed 
to it (i.e. a crossover phase between Post 1 and Post 2 in Figure 2g).  
Finally, a scenario like that of 2h, where following the treatment phases both treated and untreated 
items and the unrelated control task improve, makes it most likely that the improvements are not 
specific to the treatment or that the control task contains processing components shared by the 
treated task and influenced by the intervention. This would be the pattern one might expect not 
only with placebo or Hawthorne effects, but also in the scenario suggested by Thompson (2015, this 
issue): the participant was unwell during the course of the pretreatment baseline but is much 
improved at posttest.  
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In sum, as noted above (generalisation across sets), there are some scenarios where no approach 
can distinguish 'real' effects from artefacts - the important point is that, whichever approach is used, 
design features are incorporated to maximise the chance of being able to do so, and, of course, 
statistics used to evaluate the results.  As Johnson & Kiran (2015, this issue) note the significant 
advantage of single case studies is that threats to the validity of research can be navigated with 
flexibility and that strict adherence to a single design strips away much of that flexibility.  
Furthermore, while not discussed here, if maintenance of treatment effects beyond the treatment 
period is of interest (as it usually is), then multiple assessments points should be included at posttest 
(Johnson & Kiran, 2015). Similarly, should the purpose be to compare the effectiveness of two 
different treatments (Laganaro, 2015, this issue) then subsequent phases can be incorporated to 
enable this comparison. 
Number and characteristics of pre-treatment baselines. 
Both we and the advocates of Approach A promote the use of multiple baselines, but there are 
differences in the recommendations and requirements of each approach (Howard et al. , 2015, this 
issue). 
Number of baselines 
As McDonald (2015, this issue) notes, Tate et al (2013; ROBiNT 3: Sampling of behaviour) follow 
Horner, Carr, Halle, McGee, Odom & Wolery (2005) and Kratochwill, Hitchcock, Horner, Levin, 
Odom, Rindskopf & Shadish (2010) in setting a criterion of at least 5 data points in every phase (we 
will return to within therapy probing later). Reduced credit is given for 3 data points.  It is unclear 
from these sources what the justification is for 'at least 5'.  Thompson (2015, this issue) differs in 
suggesting that in Approach A there is no requirement to test many times before treatment and 
suggests a minimum of two to three measures, but should performance be fluctuating or increasing 
then baseline probing is continued.  
Role of Baselines 
Howard et al (2015, this issue) discuss the problems with continuing probing until stability is 
achieved as advocated by Approach A4, providing simulations to support these assertions5. In 
addition, the requirement for steady-state baselines (Goldstein, 2015, this issue) means that 
Approach A has limited applicability for populations where this is not achievable (e.g. acute aphasia, 
developmental populations). While disagreeing with a requirement for steady state baselines, we 
agree that the key function of the baseline probes is to provide information regarding trend and 
variability (Kearns, 2015, this issue; McDonald, 2015, this issue). A minimum of two baselines is 
required to provide confidence intervals on the level and trend at baseline, however, of course, 
confidence will increase with greater numbers of observations (and larger set sizes). Finally, we wish 
to make it clear that we have no in principle objection to the use of many baseline probes. Indeed, 
                                                          
4
 However, as noted by McDonald (2015, this volume), not all those who in general use Approach A design 
principles use the criterion of stability of baseline (e.g. Kiran & Johnson, 2008). 
5
 Thompson (2015, this volume) suggests that in Approach B stable pre-treatment is desired. This is not the 
case. While a stable pre-treatment performance provides the most straightforward pattern to evaluate change 
as a result of treatment, the use of statistics comparing rate of change across treated and untreated phases 
(WEST-ROC) means that the effectiveness of treatment can be evaluated even when there is an upward trend 
over baseline.  
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when dependent variables are extremely variable from session to session, this is crucial. Critically, 
the benefit of many baselines for statistical reliability needs balancing against the practical and 
ethical considerations of extended baseline testing (e.g. McDonald, 2015, this issue). 
 
Baselines and Regression to the Mean 
Kratochwill et al. (2010, p.9-10) note the problems that ensue when cases (e.g., items, participants, 
schools) are selected on the basis of extreme scores. In this case, their score when remeasured will 
typically be less extreme. This effect is regression to the mean and Howard et al. (2015, this issue) 
discuss the issue in detail. Kratochwill et al. note that it is a particular problem when baseline 
assessments are performed and then the to-be-treated stimuli are selected on the basis of poor 
performance on the baseline. This point is also stressed in our target article (Howard et al., 2015, 
this issue) and supported by Willmes (2015, this issue). In this case, regression to the mean is likely 
to result in improved performance at the next probe which can be confused with an effect of 
treatment, and more commonly with generalisation of treatment effects to untreated items. As 
discussed in our target article (Howard et al., 2015, this issue) there are a number of ways to avoid 
regression to the mean, for example matching treated and untreated sets or tasks for baseline 
performance (without excluding any items). This has the added benefit of including ‘easier’ items as 
part of the intervention. We strongly recommend that researchers do not select items or tasks on 
the basis of poor performance at baseline. If ‘difficult’ items are to be the target of treatment, they 
must be chosen in a ‘selection phase’ before the start of the baseline testing phase. The baseline 
assessment phase will then identify the extent of any regression to the mean. The potential trap of 
regression to the mean is one that affects all researchers, regardless of the approach they use. 
Within treatment sampling of behaviour 
As noted above, Tate et al. (2013) require sampling within every phase (ROBiNT 3: Sampling of 
behaviour) on at least five occasions. The requirement to sample within the treatment phase is a key 
distinction between the two approaches. Advocates of Approach A argue that this probing is 
necessary for experimental control, specifically, in order to determine that changes in the rate and 
trend of change coincides with the onset of treatment (e.g., Kearns, 2015, this issue). For example, 
Kratochwill and Levin (2010, Table 1) state that “the manipulated variable is introduced and 
concomitant changes in the outcome measure(s) are assessed in the level, trend, and variability 
between phases of the series.” However, consider the scenarios in Figure 3. In both Figures 3a and 
3b the baseline levels and rate of change are equivalent, and so are the final levels of performance 
and rate of change at the post test phase.  
However, critically it is only in 3a that the onset of the change in trend occurs simultaneously with 
the onset of treatment. As Kratochwill et al. (2010, p18) note, for Approach A “The more rapid (or 
immediate) the effect, the more convincing the inference that change in the outcome measure was 
due to manipulation of the independent variable. Delayed effects might actually compromise the 
internal validity of the study.” Yet one can imagine many scenarios where the onset of treatment 
might not result in immediate change in probe measures despite the treatment being the cause of 
the effects when they do occur. This could be the result, for example, of a severe naming 
impairment resulting in the need for several exposures during the treatment task (e.g. semantic 
feature analysis) before benefit is observed in unaided naming, or in a task requiring learning (such 
as reacquisition of letter-sound correspondence rules) where such learning takes time, or when 
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learning to use a new strategy in conversation where awareness of the need for repair is likely to 
precede change in behaviour entailing use of the new strategy. Hence, the interpretation of within 
treatment probing as required by Approach A can be less that straightforward. In contrast, in 
Approach B and using WEST statistics as advocated by Howard et al., both scenarios shown in 3a and 
3b would be interpreted as indicating a significant treatment effect. 
 
Figure 3:  Illustration of when changes in trend do (3a) and do not (3b) coincide with the onset of 
treatment. 
 
 
Howard et al. (2015, this issue) discuss three potential problems with the requirement for repeated 
probing:  
 Repeated probing may influence performance  
Goldstein (2015, this issue) asserts that any effects of repeated probing are ‘small at best’. That may 
be true, but they are present (e.g., Abel, Schultz, Radermacher, Willmes, & Huber, 2005; Howard, 
Patterson, Franklin, Orchard-Lisle, & Morton, 1985; Martin, Fink, Renvall, & Laine, 2006 Nickels, 
2002a), and to unpredictable extents across individuals. Hence, given that treatment effects are also 
not guaranteed, and may be small, there is a very real risk of repeated probing effects being 
interpreted as treatment effects. Indeed, it has been acknowledged that effects that have been 
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interpreted in the past as reflecting generalisation may have in fact been effects of repeated probing 
(e.g. Boyle 2011 on semantic feature analysis; Howard 2000, on Howard et al., 1985) 
Figure 4: The pattern of results consistent with effects of repeated probing on performance 
 
 
Paradoxically, the potential effects of repeated probing on performance actually biases towards the 
need for probing on an untreated set of items. If for example, treatment first requires the individual 
to attempt to name the picture before the therapeutic intervention (e.g., cueing, repeating, 
semantic feature analysis), then repeated probing is required to be sure that it is the therapeutic 
intervention rather than the attempts at naming that have produced the effect6. Hence, comparison 
is required between a set that are probed as often as the treated items are named (‘untreated 
probed’ or ‘naming controls’) and a set that are only probed before and after treatment (‘untreated 
unprobed’ or ‘unseen’) (Johnson & Kiran, 2015, this issue). Figure 4 illustrates the pattern consistent 
with an effect of repeated probing with no additional benefit from intervention. 
 Repeated probing may not be possible in practice 
Howard et al. note that under some conditions repeated probing may not be possible, including in 
the case of home programmes. Furthermore, as McDonald (2015, this issue) notes, it is also the case 
that some participants cannot or will not tolerate repeated probing, particularly when this is on a 
task that is difficult for them to perform. The added time constraint of probing on top of treatment 
can also be unfeasible for those individuals with limited attention or stamina (even when a reduced 
probing set is used as suggested by Thompson (2015, this issue)). 
 Repeated probing biases towards small-n therapy sets 
Howard et al. discuss in depth the benefits of larger sets of items for the evaluation of the effects of 
treatment. However, with repeated probing, to reduce how onerous this is, there is a bias towards 
using smaller items sets. While we appreciate Thompson’s (2015, this issue) point that sampling of a 
                                                          
6
 Of course, in some situations this may not be a question of interest: what may be important is that the 
treatment as a whole has been effective, and whether that is the naming component or the other aspects of 
the intervention may be unimportant. 
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subset of the stimuli to probe on each occasion reduces the strength of this bias, unfortunately 
sampling brings in an additional source of noise and presents difficulty with statistical evaluation 
when different items are tested at each time point.  
Several commentators raised the issue of the practicality and feasibility of large item sets (Hillis, 
2015, this issue; Goldstein, 2015, this issue; Johnson & Kiran, 2015, this issue; McDonald, 2015, this 
issue).  We reiterate that 30 is not a magic number - it may need to be less and it may be able to be 
more: more items mean more power for statistical analysis, hence when more items are available 
and practical we would recommend they are employed. Moreover, at least for anomia treatment, it 
seems that the more items that are treated the greater the number of items that improve (Laganaro, 
Di Pietro & Schnider, 2006; Snell, Sage & Lambon Ralph, 2010).  
However, clearly statistical power is not the only factor. First, there is the difficulty of the task for the 
person with aphasia. If they can only tolerate a small number of items in the assessment task at any 
one point in time, then the task can be split over a number of sessions (with these sessions close in 
time and allocation of items to sessions being randomly determined). Similarly, if the treatment task 
is one that is time consuming for each item (e.g. semantic feature analysis) then not every item need 
be treated at every point of time and the length of the treatment programme extended to ensure 
sufficient dosage (Johnson & Kiran, 2015, this issue). Second, there is the issue of naturally restricted 
sets of items. Hillis (2015, this issue) provides the example of training grapheme-phoneme 
conversion, where each of three sets were necessarily restricted to 10 items each. While it is not 
possible to ‘create’ more of a restricted set, it might be possible to test also this skill in a different 
way, which may allow greater number of items to be included. For example, by examining reading of 
words (or nonwords) that contain trained graphemes versus those that contain untrained 
graphemes. Similarly, while there may be only a limited range of facial emotions (6 basic facial 
expressions of emotion; McDonald, 2015, this issue), it is possible to sample each emotion several 
times across different faces, thereby providing a larger pool of stimuli for analysis. McDonald also 
gives examples of behavioural treatments where a limited set of behaviours are defined and 
monitored and suggests that this would  be hard to accommodate with the need for larger item sets. 
Once again, while acknowledging that it is less straightforward than with a set of words, it will often 
be possible. For example, if “meal preparation” is a behaviour that is to be monitored (and 
presumably intervention provided), this is not a single indivisible entity, but rather comprises a set of 
specific sub-behaviours, for example,  retrieve ingredient 1, ingredient 2, ingredient 3, retrieve 
utensils 1, 2, 3, cut ingredient 1,cut ingredient 2 etc. At each monitoring point success in carrying out 
each of these subcomponents is noted and these comprise the data for statistical analysis. 
Summary - within treatment probing 
In sum, we have no in principle objection to the use of within treatment probing. However, we do 
not consider it a requirement for experimental control and it is clear that it entails practical 
constraints. As Hillis (2015, this issue) notes, whether or not you choose to probe frequently 
depends on the hypothesis you want to test.  
Replication 
Several commentators point out that replication is central to Approach A (e.g., Goldstein, 2015, this 
issue; McDonald, 2015, this issue; Thompson, 2015, this issue). Correspondingly this is one of the 
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elements in the ROBiNT scale: Item 1 (Design) requires at least 3 replications of the treatment effect 
for full marks and Item 14 (Replication) refers to the repetition of the entire experiment across 
subjects (again 3 times for full marks). Replication was not addressed in Howard et al. (2015, this 
issue) and we wish to make clear that we absolutely agree that the weight of evidence for an effect 
is increased by replication within an individual. As illustrated in the examples in Figures 1 and 2 
above, incorporating replication of treatment using a second set of previously untreated stimuli in 
the same individual can be extremely valuable. However, we disagree with Thompson (2015, this 
issue) and as argued above, believe there are conditions under which a change in performance from 
baseline to treatment can constitute evidence for an effect of treatment (i.e. experimental control; 
e.g. Figure 2c, earlier) without replication. 
Moreover, we would note that direct replication of the treatment effect within subjects is not 
always possible. For example, if one is teaching a strategy (e.g., for use in reading, or naming, or 
conversation) once the subject has acquired this strategy, it will not be possible to replicate this 
therapy phase. Similarly, if, for example, a particular syntactic structure is acquired, while there may 
be the potential to teach another syntactic structure, direct replication will not be possible. 
Moreover, whether or not the subject acquires the second syntactic structure has no impact on the 
strength of evidence for the effect of treatment on the first syntactic structure.  
Replication across individuals and across settings is also informative and important in building a 
evidence base. As Thompson (2015, this issue) notes the more replications there are, the greater the 
confidence we can have that the treatment effect is generalizable to other people with aphasia with 
similar language deficits. However, there is a crucial difference between type A and B approaches 
with regard to replication across participants. In type A, replication across participants is a design 
feature which can help establish the effectiveness of an intervention. In type B, successful 
replication across individuals provides evidence that an intervention can be effective in those 
different individuals. However, should a treatment fail to replicate in another individual with 
aphasia, this in no way decreases the strength of evidence regarding a positive effect of treatment in 
the first individual. Instead, the reasons for the different effects of treatment should be sought (be 
they differences in impairments, retained language abilities or slight differences in how the 
treatment was enacted; e.g., Best & Nickels, 2000).  
In sum, replication of treatment effects within an individual increases the strength of evidence for 
the original treatment effect. Replication across individuals (or across settings) does not impact on 
the strength of evidence of an original treatment effect in a first individual, but increases evidence 
regarding the conditions under which that treatment is effective.  
Randomisation 
On the RoBiNT scale (Tate et al, 2013), item 2 refers to randomisation. We have already stressed the 
need for randomisation of items into sets and sets to conditions. It is important that there is random 
selection of which sets are to be treated, or which are to be treated first, or which are to receive 
treatment A and which treatment B (Willmes, 2015, this issue). However, while randomisation of 
sequence or treatment is encompassed by this item on the ROBiNT scale, it also refers to 
randomisation of the specific time points at which each of the different phases commence (A and B). 
Note, however, that randomisation of when the second A phase begins, also implies randomisation 
of when treatment phase B ends. This seems to be at odds with either a criterion-referenced start to 
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treatment (dependent on stability), end to treatment (e.g. finish when 80% accuracy is achieved) or 
a fixed number of treatment sessions (e.g. finish after 20 sessions). The rationale behind this is 
closely related to the need to examine when the trend changes in the data (i.e. when improvement 
starts). We have no strong views on this aspect of randomisation, but remain to be convinced that it 
adds greatly to the strength of evidence over and above a pre-chosen length of phase. 
 
Data analysis 
In Howard et al (2015, this issue) we argued strongly that statistical analysis is required in order to 
determine whether or not a treatment has been effective, to compare the effectiveness of one kind 
of treatment over another or the effectiveness of the same treatment on two different kinds of 
stimuli. Having considered all the commentaries in detail, we hold firm to this view. Tate et al. (2008) 
in their original Single Case Experimental Design Scale also required statistical analysis (Point 9, 
Appendix, p401 “To demonstrate the effectiveness of the treatment of interest by statistically 
comparing the results over the study phases”). In Howard et al., we also provided some new 
statistical methods (Weighted Statistics - WEST) that we believed would be useful to researchers and 
clinicians in evaluating their treatment. In this section, we address issues raised by the 
commentators regarding data analysis.  
Visual Analysis 
We should note that it is good practice as part of all statistical analysis to examine the patterns in 
the data - in that sense we support visual inspection of the data. Statistical analysis without visual 
inspection can lead to mistaken interpretation of the meaning of the statistics.  
Our target article included a number of reasons for scepticism about ‘visual analysis’ as a reliable 
method for detecting real therapy effects. While some commentators agree that visual analysis is 
'flawed' (Kearns, 2015, this issue), other commentators (e.g., Martin & Kalinyak-Fliszar, 2015, this 
issue) note that there are techniques that may assist in improving its reliability. Moreover, since we 
wrote the target article there have been articles that promote a very disciplined approach to visual 
analysis including a variety of quasi-statistical evaluation methods (e.g., Brossart, Vanest, Davis and 
Patience, 2014; Lane & Gast, 2014,as part of a special issue of Neuropsychological Rehabilitation 
(volume 24, issue 3-4, 2014) devoted to single case experimental design for rehabilitation). These 
build on proposals by Kratchowill et al (2010, 2013) but are not used widely in practice and their 
validity has yet to be tested.  
Interestingly, while Tate et al. (2008) required statistical analysis, Tate et al. (2013) do not (ROBiNT 
item 13: Data Analysis), stating, “Controversy remains about whether the appropriate method of 
analysis in single-case reports is visual or statistical. Nonetheless, 2 points are awarded if systematic 
visual analysis is used according to steps specified by Kratochwill et al. (2010; 2013), or visual 
analysis is aided by quasi-statistical techniques, or statistical methods are used where a rationale is 
provided for their suitability. One point is awarded if systematic/aided visual analysis is 
incomplete/not conducted for every phase change or no rationale is provided for statistical 
analysis”. 
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Unfortunately, therefore, it seems that there is not a consensus that “Visual inspection of data is not 
an adequate analysis” (Beeson, 2015, this issue, Table 1), although, like Beeson, we hold this view. 
Many of the other commentators also acknowledge that visual analysis has shortcomings and/or 
they are generally supportive of the need for statistical analysis or the use of statistical analysis to 
supplement visual analysis (e.g., Hillis, 2015, this issue; Kearns, 2015, this issue; Martin & Kalinyak-
Fliszar, 2015, this issue; McDonald, 2015, this issue; Thompson, 2015, this issue).  
Effect Sizes 
In Howard et al. (2015, this issue) we discussed several concerns with the use of effect size statistics. 
(See below for discussion regarding other concerns about interpretation of effect sizes raised by 
Fischer-Baum (this issue)). Beeson (2015, this issue) discusses effect size statistics in some detail and 
makes an important and insightful distinction between primary and secondary statistical analyses: 
the weighted statistics that we propose, along with other non-parametric analyses used in the past 
(e.g. McNemars, Cochran’s Q, Wilcoxon Matched pairs) are examples of primary analyses which 
answer the question of whether a treatment is effective. In contrast, measures of effect size, 
including Busk and Serlin’s d, are an example of secondary statistical analysis. Secondary statistical 
analyses aim to provide a standard quantification of treatment effects so that findings can be 
combined and synthesised across studies in meta-analysis of effects. As Beeson notes, in this sense 
primary and secondary analysis procedures are complementary rather than competing approaches. 
Beeson also correctly surmises, that while we do have concerns with the use of Busk and Serlin’s d1 
statistic, our primary frustration is that this is often the only analysis that is reported. We are glad 
that this frustration is not ours alone! Moreover, if item level data are reported routinely, secondary 
analysis can also be performed from the weighted statistics proposed here.   
Weighted Statistics 
In the target paper we introduced methods for using λ coefficients to evaluate treatment effects 
independently from any overall linear change over the investigation period. We argued for a simple 
method that involved using t tests to investigate treatment effects. We have conducted extensive 
simulations of these methods varying serial dependency between items (i.e. autocorrelation) and 
are confident that they can give reliable results including effect sizes and their associated confidence 
intervals, over a wide range of the number of trials and the number of items. 
Three of the commentators (Fischer-Baum, 2015, this issue; Laganaro, 2015, this issue; Willmes, 
2015, this issue) while being broadly supportive of our desire to introduce statistical rigour to 
therapy studies of single subjects, criticise some aspects of our suggested method. 
Laganaro (2015, this issue) argues that because the underlying distribution in our example is not 
normal by a Shapiro-Wilk test, we cannot use a t test to evaluate results. She has a widely held, but 
incorrect, understanding of when t tests can/should be used. The t test tests just the mean of a 
distribution and assumes only that the mean is normally distributed. The Central Limit Theorem 
guarantees that the mean from a distribution of any shape will be normally distributed as the 
number of items tends to infinity. How rapidly it converges to  normal is largely determined by the 
degree of skew in the underlying distribution. Our simulations suggest that even with small sample 
sizes and high item-level serial dependency, the assumption of normality for the means doesn’t lead 
to a raised type I error. In other words, t-tests are entirely appropriate for this kind of data.  
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Laganaro suggests instead that the data should be analysed using growth curve analysis with 
binomial outcomes using R. As far as we know R is the only statistical package that can be used to do 
this. Mirman (2014) provides a very helpful handbook on how one might use R to address these 
analytic issues. The λ coefficients, that we argue for, apply equally to this approach. Mirman (2014) 
notes that one can use specific coefficients in such analysis in R but this is ‘rather challenging’ (p. 45). 
Laganaro correctly points out that this method of analysis will allow the investigation of the effects 
of a covariate and its interactions with treatment and recovery effects.There is no doubt that 
logistic/binomial modelling of growth cuves using R would be possible and sensible with the data 
from treatment studies. We think it is likely that under almost all circumstances this would produce 
very similar results to our method; but any conclusive comparison of these approaches will have to 
be based on a systematic analysis. 
Fischer-Baum (this issue) raises a very important question about how we should interpret 
improvement. His point is that one should not assume that a change of 20% from say 40 to 60% is 
the same as a change from 70 to 90%. We would agree, and not only because of the shape of the 
logistic curve – which is Fischer-Baum's focus. The problem is that the assessments used as outcome 
measures in most therapy studies do not have the psychometric properties to make these 
comparisons possible. 
Any such comparison has to make some kind of assumption about the predicted shape of change. 
Most analyses of therapy studies implicitly or explicitly assume that changes should be broadly linear 
within and across phases: in our Newtonian universe we believe that data, just like objects, will 
continue in a straight line except where they are acted on by some external force, in this case 
therapy intervention. While at first sight sensible, there are reasons for doubting this belief.  
For example, an implicit assumption is often made that steady changes in a patient’s ability will be 
reflected in steady changes in probe test performance. What is less often realised is that this is only 
true when a test’s items are equally spaced for difficulty. We simply do not know this for any 
assessment used in language testing, and given that people with language impairments differ in 
what affects their performance, the difficulty gradients will almost certainly differ for different 
people. It is not at all clear in principle or in practice how one might account for this. 
We have to assume, then, that the assessments used to evaluate therapies do not necessarily have a 
linear relationship between ability and score. They may be ‘lumpy’, in the sense that the same 
change in ability at one point in the scale may result in a much larger change than at another point in 
the scale. Once we realise this, we know that we cannot be sure of the shape of change in any test 
or assessment. Comparisons based on differences in slope between phases or differences in the 
amount of improvement for different sets need to be viewed with caution because equal changes in 
underlying ability do not necessarily result in equal changes in score. 
However, in the target article, we were arguing for random assignment of items to sets. Random 
assignment avoids, essentially, all arguments based on the shape of relationship between ability and 
score. When items are randomly assigned at baseline, significance tests for differences in change 
between treated and untreated sets make no assumptions about the shape of the relationship 
between ability and score. 
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While, as Laganaro (2015, this volume) and Fischer-Baum (2015, this volume) suggest, the ability-
score relationship for individual items can be plausibly modelled by a logistic function (with a 
different intercept and slope for each item) the sum/average of a set of logistic functions will be 
approximately normally distributed (see Audley & Jonckheere, 1956 for helpful discussion). How 
rapidly it converges to the normal distribution will depend on the skew of the expected distribution 
under the null hypothesis. Where there is any doubt we suggested, in our target paper, using 
randomisation tests (e.g. “randomise” in SPSS) , and Fischer-Baum endorses this approach.  
However, we think these different statistical approaches should nearly always produce similar 
results. We note, though, that the randomisation tests necessarily assume random assignment of 
items to sets (as we recommend). 
Laganaro (2015, this issue) also raises the point that, in the target article, we did not address what 
hypotheses should be addressed in the statistical analysis of  a treatment study. She points out 
absolutely correctly that we report 10 different comparisons in table 5.1. Our purpose there was 
simply to point out possible comparisons and how they can be carried out. As in any experimental 
investigation one has to think about the hypotheses and use the appropriate statistics that allow one 
to address them. For example, were we to have a therapy experiment with three phases (pre-
treatment baseline, treatment, and post-treatment follow-up) and two randomly-allocated sets of 
items one of which was treated in the intervention phase, the following hypotheses would be 
relevant: 
(i) Is there overall improvement over all items over the course of the study? 
(ii) Is there greater improvement during the treatment period than the untreated periods? 
(iii) Is the overall improvement different for treated and untreated sets? (i.e. Is there an 
interaction between set and overall improvement?). 
(iv) Is the amount of greater improvement during treatment greater for the treated set than 
the untreated set? (i.e. Is there an interaction between set and greater improvement 
during therapy?) 
Were any of the interactions here significant, one would sensibly use post hoc comparisons to try to 
understand better the meaning of the results. Table 5.1 was meant to facilitate appropriate 
comparisons. This is ordinary experimental analysis, with nothing controversial or innovative. 
Willmes (2015, this issue) writes a generally supportive commentary, but takes issue with three 
topics. First, he argues that we have misinterpreted Matthews, Altman, Campbell and Royston 
(1990). Matthews et al argued (although they were not the first to do so) that reducing an effect of 
interest to a single number (e.g. ‘greater during therapy’) would always avoid any problem with 
autocorrelation in serial data. Willmes points out correctly that Matthews et al only made that 
argument for the case where units of (statistical) analysis  were subjects, and we are extending this 
argument to the case where the units of analysis are items. We have two responses, both of which 
suggest that Willmes is incorrect. The first is that Matthews et al.’s argument is not about items or 
subjects but, in essence, about units of analysis; the statistics don’t know anything about the units of 
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analysis. The second is that we have conducted many simulations that show that whatever the item-
level dependency 7(i.e. lag 1 autocorrelation) our methods work. 
Second, Willmes suggests that  non-parametric procedures might be better. This is a question we 
have also explored in detail using simulations. It turns out that (i) where the λ coefficients have no 
skew, the Wilcoxon one-sample test performs well but with lower power than the t test; (ii) where 
there is skew in the λ coefficients the Wilcoxon one-sample test performs very poorly (because the 
null hypothesis is based on the assumption that the mean of the differences is zero and the 
differences are symmetrically distributed). In short, our simulations have demonstrated that non-
parametric methods always perform worse than the simple t test, so we recommend use of the t-
test. 
Third, Willmes argues that we should consider instead statistical methods that are based on the 
assumption, for the null hypothesis, of permutability of observations from individual items across 
testing sessions. While these methods are very attractive, unfortunately they should not be used. 
The reason is that, in intervention data, there can be item-level between-session dependency (i.e. 
lag 1 autocorrelation), and it would be unwise to make the assumption that there is permutability. 
We currently have data showing that there can be substantial item-level between session 
dependency, in naming, for at least one person with aphasia. 
To summarise, we argued in the target paper (Howard et al, 2015, this issue) that we could and 
should use appropriate statistical methods in analysing treatment studies with a single participant 
and case series. We offered a simple method that is easily implemented, that we have referred to as 
WEighted STatistics (WEST). Laganaro (2015, this issue) and Fischer-Baum (2015, this issue) correctly 
pointed out that there are other ways of statistically modelling such studies. There may be other 
approaches, but all will fall under the umbrella of ‘growth curve analysis’ (e.g. Mirman 2014). We 
consider that our approach using λ coefficients to focus on the effects/hypotheses of interest (e.g. is 
there overall improvement? Is there greater improvement during periods of treatment than when 
there is no treatment?) is valuable and should be applied whatever the statistical model.   
Conclusion.  
As Martin and Kalinyak-Fliszar (2015, this issue, pXX) note  the “unique dynamic of matching 
treatment to impairment profile and goals of the person with aphasia ... has been central to the 
science and ‘art’ of aphasia rehabilitation, but at the same time presents challenges in testing the 
efficacy of behavioral treatments for aphasia.” 
Far from " abandoning single subject controlled experimental research" (Thompson, 2015, this issue) 
we wish to ensure that all clinical scientists and scientific clinicians embarking on single subject 
intervention research use designs which enable experimental control to be maintained.  There is no 
'one size fits all' design. Each individual or research team must choose those elements that are 
required to answer their research or clinical question and fit within the needs and practical 
constraints of the particular treatment and particular participant (Hillis, 2015, this issue; Johnson & 
Kiran, 2015, this issue).  
                                                          
7
 By item-level dependency we mean that for any item the probability correct on trial n depends on the 
performance for that item on trial n-1 
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Finally, as Tate, Perdices, Mcdonald, Togher and Rosenkoetter (2014) note, it is not enough for 
researchers to design and carry out single case studies of intervention adequately, they also need to 
be adequately reported so that their quality can be assessed by the reader and others can replicate 
the design. Tate et al. (2014) report that a set of guidelines are currently under development: Single-
Case Reporting guideline In BEhavioural interventions (SCRIBE). The aim of these guidelines is to 
provide a set of essential features that should be included when reporting single cases, but are not 
prescriptive regarding design and implementation. We hope that with the publication of these 
guidelines reporting will improve as was observed when the CONSORT (Consolidated Standards of 
Reporting Trials) guidelines for randomised controlled trials came into use (Begg et al., 1996). 
In sum, we agree wholeheartedly with Goldstein (2015, this issue, pXX) that properly controlled 
experimental investigations of intervention effects “are not merely means of evaluating treatments; 
they offer a scientific tool for refining our understanding of behavioral phenomenon [sic]. 
Understanding variables that inhibit or enhance variability in performance is critical to an iterative 
process of developing robust treatments.”  
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